449 related articles for article (PubMed ID: 25996682)
41. Characterization of tissue-specific differential DNA methylation suggests distinct modes of positive and negative gene expression regulation.
Wan J; Oliver VF; Wang G; Zhu H; Zack DJ; Merbs SL; Qian J
BMC Genomics; 2015 Feb; 16(1):49. PubMed ID: 25652663
[TBL] [Abstract][Full Text] [Related]
42. Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia.
Jost E; do O N; Wilop S; Herman JG; Osieka R; Galm O
Leuk Res; 2009 Mar; 33(3):443-9. PubMed ID: 18757096
[TBL] [Abstract][Full Text] [Related]
43. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
Sun GK; Tang LJ; Zhou JD; Xu ZJ; Yang L; Yuan Q; Ma JC; Liu XH; Lin J; Qian J; Yao DM
Cancer Med; 2019 Oct; 8(14):6393-6402. PubMed ID: 31486300
[TBL] [Abstract][Full Text] [Related]
44. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
[TBL] [Abstract][Full Text] [Related]
45. Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia.
Yamazaki J; Taby R; Jelinek J; Raynal NJ; Cesaroni M; Pierce SA; Kornblau SM; Bueso-Ramos CE; Ravandi F; Kantarjian HM; Issa JP
J Natl Cancer Inst; 2015 Nov; 108(2):. PubMed ID: 26568194
[TBL] [Abstract][Full Text] [Related]
46. Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia.
Shimamoto T; Ohyashiki JH; Ohyashiki K
Leuk Res; 2005 Jun; 29(6):653-9. PubMed ID: 15863205
[TBL] [Abstract][Full Text] [Related]
47. Differential TERT promoter methylation and response to 5-aza-2'-deoxycytidine in acute myeloid leukemia cell lines: TERT expression, telomerase activity, telomere length, and cell death.
Pettigrew KA; Armstrong RN; Colyer HA; Zhang SD; Rea IM; Jones RE; Baird DM; Mills KI
Genes Chromosomes Cancer; 2012 Aug; 51(8):768-80. PubMed ID: 22517724
[TBL] [Abstract][Full Text] [Related]
48. Developing DNA methylation-based prognostic biomarkers of acute myeloid leukemia.
Gao C; Zhuang J; Zhou C; Liu L; Liu C; Li H; Zhao M; Liu G; Sun C
J Cell Biochem; 2018 Dec; 119(12):10041-10050. PubMed ID: 30171717
[TBL] [Abstract][Full Text] [Related]
49. Methylation of CTNNA1 promoter: frequent but not an adverse prognostic factor in acute myeloid leukemia.
Chen XX; Lin J; Qian J; Qian W; Yang J; Ma JC; Deng ZQ; An C; Tang CY; Qian Z; Liu Q
Leuk Res; 2014 May; 38(5):613-8. PubMed ID: 24685333
[TBL] [Abstract][Full Text] [Related]
50. Modifications of H3K4 methylation levels are associated with DNA hypermethylation in acute myeloid leukemia.
Scalea S; Maresca C; Catalanotto C; Marino R; Cogoni C; Reale A; Zampieri M; Zardo G
FEBS J; 2020 Mar; 287(6):1155-1175. PubMed ID: 31599112
[TBL] [Abstract][Full Text] [Related]
51. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
[TBL] [Abstract][Full Text] [Related]
52. Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genes.
Qu Y; Lennartsson A; Gaidzik VI; Deneberg S; Karimi M; Bengtzén S; Höglund M; Bullinger L; Döhner K; Lehmann S
Epigenetics; 2014 Aug; 9(8):1108-19. PubMed ID: 24866170
[TBL] [Abstract][Full Text] [Related]
53. Detection of differential mitotic cell age in bone marrow CD34(+) cells from patients with myelodysplastic syndrome and acute leukemia by analysis of an epigenetic molecular clock DNA signature.
Mossner M; Hopfer O; Nowak D; Baldus CD; Neumann U; Kmetsch A; Benlasfer O; John T; Perka C; Thiel E; Hofmann WK
Exp Hematol; 2010 Aug; 38(8):661-5. PubMed ID: 20399247
[TBL] [Abstract][Full Text] [Related]
54. NDRG2 and TLR7 as novel DNA methylation prognostic signatures for acute myelocytic leukemia.
Ge F; Zhang P; Niu J; Pei X; Lian C; Yu R; Ma R; Zhang Y; Zhu Z; Sun K
J Cell Physiol; 2020 Apr; 235(4):3790-3797. PubMed ID: 31613009
[TBL] [Abstract][Full Text] [Related]
55. The 5' flanking region of miR-378 is hypomethylated in acute myeloid leukemia.
Zhu XW; Wen XM; Zhang YY; Yang L; Guo H; Yang J; Zhang M; Yin JY; Ma JC; Lin J; Deng ZQ; Qian J
Int J Clin Exp Pathol; 2015; 8(5):4321-31. PubMed ID: 26191124
[TBL] [Abstract][Full Text] [Related]
56. Level of HOXA5 hypermethylation in acute myeloid leukemia is associated with short-term outcome.
Kim SY; Hwang SH; Song EJ; Shin HJ; Jung JS; Lee EY
Korean J Lab Med; 2010 Oct; 30(5):469-73. PubMed ID: 20890077
[TBL] [Abstract][Full Text] [Related]
57. HOXD13 methylation status is a prognostic indicator in breast cancer.
Zhong Z; Shan M; Wang J; Liu T; Xia B; Niu M; Ren Y; Pang D
Int J Clin Exp Pathol; 2015; 8(9):10716-24. PubMed ID: 26617782
[TBL] [Abstract][Full Text] [Related]
58. CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes.
Benetatos L; Hatzimichael E; Dasoula A; Dranitsaris G; Tsiara S; Syrrou M; Georgiou I; Bourantas KL
Leuk Res; 2010 Feb; 34(2):148-53. PubMed ID: 19595458
[TBL] [Abstract][Full Text] [Related]
59. Placentas from pregnancies conceived by IVF/ICSI have a reduced DNA methylation level at the H19 and MEST differentially methylated regions.
Nelissen EC; Dumoulin JC; Daunay A; Evers JL; Tost J; van Montfoort AP
Hum Reprod; 2013 Apr; 28(4):1117-26. PubMed ID: 23343754
[TBL] [Abstract][Full Text] [Related]
60. Comparison of promoter DNA methylation and expression levels of genes encoding CCAAT/enhancer binding proteins in AML patients.
Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Baranowska A; Siedlecki JA
Leuk Res; 2014 Jul; 38(7):850-6. PubMed ID: 24878001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]